PaxMedica, Inc. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported net loss was USD 16.46 million compared to USD 3.45 million a year ago. Basic loss per share from continuing operations was USD 2.5 compared to USD 0.85 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.317 USD | -14.32% | -57.15% | -58.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.12% | 2.37M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- PXMD Stock
- News PaxMedica, Inc.
- PaxMedica, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021